Cancer research is increasingly intertwined with biotechnology, leveraging cutting-edge tools and methodologies to unravel the complexities of this disease. From high-resolution imaging techniques facilitating early detection to customized therapies tailored to individual genetic profiles, biotechnology is reshaping how we approach cancer treatment. Biomarker identification, genomic sequencing, and precision medicine strategies are at the forefront, guiding clinicians towards more targeted and effective interventions. Moreover, innovative drug delivery systems, like nanoparticles and gene editing technologies, hold promise for reducing side effects and enhancing therapeutic outcomes. This fusion of cancer research and biotechnology heralds a new era in oncology, offering unprecedented opportunities to combat this formidable adversary and improve patient care worldwide.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States